Global Market Access & Pricing Consultant (FR/EN)

Eversana; Paris; Hybrid; EUR 70,000 - 100,000; Full time

Job summary

EVERSANA is seeking a Consultant for Global Market Access & Pricing who is fluent in French and English and ready to work across Europe and APAC. This role focuses on pricing, HTA, and market access strategy, offering exposure to leading-edge AI-enabled tools and a fast-growing, multicultural team.

You will own significant project work, develop client-ready deliverables, and engage with cross-functional teams to deliver high-impact recommendations that shape patient access to therapies.

Qualifications

• 2–3 years of relevant professional experience in Market Access & Pricing, management consulting, or a highly analytical pharma role.
• Strong analytical and quantitative foundation, with the ability to structure complex problems and turn evidence into clear business implications.
• Mandatory Fluency in French, fluency in English.

Responsibilities

• Own meaningful pieces of the work: lead defined analyses and project workstreams across research, data analysis, financial modeling, and pricing and market access topics.
• Translate evidence into recommendations: turn data, research, and market insights into clear client-ready deliverables that support strategic decision-making.
• Help drive project delivery: coordinate with colleagues, track progress, support day-to-day execution, and contribute to smooth communication with client counterparts.

Skills

Analytical skills

French fluency

English fluency

Education

PhD or equivalent degree (nice to have)

Tools

Excel

PowerPoint

Job description

EVERSANA is seeking a Consultant for Global Market Access & Pricing who is fluent in French and English and ready to work across Europe and APAC. This role focuses on pricing, HTA, and market access strategy, offering exposure to leading-edge AI-enabled tools and a fast-growing, multicultural team.

You will own significant project work, develop client-ready deliverables, and engage with cross-functional teams to deliver high-impact recommendations that shape patient access to therapies.